Autopsy report · NCT01325779

Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients

“poor enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Lisa Louwers

Sponsor type

University, hospital or other

Conditions

Lower Extremity Deep Venous Thrombosis

Interventions

heparin; enoxaparin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
  “very poor enrollment” (96% match in meaning)
• Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study
  “Inadequate enrollment” (91% match in meaning)
• Tocilizumab for the Treatment of Behcet's Syndrome
  “low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.